Chrusciel M

No ORCID on file · 4 papers in corpus · active 2016-2025

Study types

  • article 1

Condition tags

  • endometriosis 1
  • endometrioma 1
2025
Targeted destruction of follicle stimulating hormone receptor-positive cancer cells in vitro and in vivo by a lytic peptide Phor21-FSHβ conjugate.
Molecular medicine (Cambridge, Mass.) ·doi:10.1186/s10020-025-01292-5

BACKGROUND: Extragonadal follicle-stimulating hormone (FSH) receptor (FSHR) expression in various cancers and their endothelial vessel cells has highlighted novel opportunities for targeted FSHR therapy. METHODS: We investigated the specifi…

2019
Extragonadal FSHR Expression and Function-Is It Real?
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00032

Expression of the follicle-stimulating hormone receptor (FSHR), besides gonadal tissues, has recently been detected in several extragonadal normal and tumorous tissues, including different types of primary and metastatic cancer and tumor ve…

article 2016
Functional Expression of FSH Receptor in Endometriotic Lesions
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2016-1014

CONTEXT: FSH receptor (FSHR), besides being expressed in gonads, is also expressed in some extragonadal tissues at low levels. OBJECTIVE: We examined the functional expression of FSHR in different types of endometriotic lesions. DESIGN: Ext…

2016
Revisiting the expression and function of follicle-stimulation hormone receptor in human umbilical vein endothelial cells.
Scientific reports ·doi:10.1038/srep37095

Expression of follicle-stimulation hormone receptor (FSHR) is confined to gonads and at low levels to some extragonadal tissues like human umbilical vein endothelial cells (HUVEC). FSH-FSHR signaling was shown to promote HUVEC angiogenesis …